Studies have shown that the therapeutic efficacy on EBI3‐deficient mice would be significantly inhibited in the IBD mouse model 25, indicating the critical role of IL‐35 in immunoregulation. The gene discussed is EBI3; the disease is inflammatory bowel disease.